Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Director/PDMR Shareholding

5 Dec 2016 14:45

RNS Number : 9971Q
ABCAM Plc
05 December 2016
 

 

For immediate release

5 December 2016

ABCAM PLC

("Abcam" or the "Company")

Director/PDMR Shareholding Notification

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, was notified on 2 December that Jim Warwick, Executive Director of the Company, on 2 December 2016 exercised options over 30,000 ordinary shares ("Ordinary Shares") of 0.2 pence each in the Company at an exercise price of 0.2 pence per share, and subsequently sold the resulting Ordinary shares at £8.08375 per share.

As a result of the transaction described above, Jim Warwick's total interest in the Company remains at 2,881,381 Ordinary Shares.

The notification for Mr Warwick can be found below. This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

##Ends##

 

For further information, please contact:

Abcam

+ 44 (0) 1223 696 000

Suzanne Smith, Company Secretary

 

J.P.Morgan Cazenove - Nominated Advisor & Corporate Broker

+ 44 (0) 20 7742 4000

James Mitford / Christopher Cargill

FTI Consulting

+ 44 (0) 20 3727 1000

Ben Atwell / Brett Pollard / Natalie Garland-Collins

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

David James Warwick

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Exercise of share options at an exercise price of 0.2 pence per share and sale of resulting ordinary shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£8.08375

30,000

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

30,000

£8.08375

£242,512.50

f)

Date of the transaction

2 December 2016

g)

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZELFBQLFZFBB
Date   Source Headline
16th Sep 20198:02 amRNSDirector/PDMR Shareholding
12th Sep 20197:00 amRNSNotice of Capital Markets Event
11th Sep 201910:33 amRNSDirector/PDMR Shareholding
11th Sep 201910:11 amRNSReplacement: Director/PDMR Shareholding
11th Sep 20197:00 amRNSDirector/PDMR Shareholding
9th Sep 20197:00 amRNSFull year results for 12 months ended 30 June 2019
2nd Sep 20193:14 pmRNSTotal Voting Rights
1st Aug 201912:10 pmRNSTotal Voting Rights
22nd Jul 20197:01 amRNSDirectorate Change
22nd Jul 20197:00 amRNSFull Year Trading Update
16th Jul 20197:00 amRNSAcquisition of Cell Lines and Lysates Portfolio
1st Jul 20199:38 amRNSTotal Voting Rights
3rd Jun 201910:45 amRNSTotal Voting Rights
2nd May 201912:53 pmRNSTotal Voting Rights
1st May 20197:00 amRNSAppointment of Joint Broker
2nd Apr 20191:13 pmRNSTotal Voting Rights
29th Mar 20197:00 amRNSCompany Secretary Change
12th Mar 20197:00 amRNSHolding(s) in Company
8th Mar 20198:57 amRNSHolding(s) in Company
4th Mar 20197:00 amRNSInterim results for six months ended 31 Dec 2018
1st Mar 201910:29 amRNSTotal Voting Rights
25th Feb 20195:39 pmRNSChange of Registered Office
18th Feb 20191:01 pmRNSBlock listing Interim Review
5th Feb 201911:34 amRNSTotal Voting Rights
28th Jan 20197:00 amRNSAcquisition of Calico Biolabs
8th Jan 20197:00 amRNSHalf Year Trading Update
3rd Jan 20191:45 pmRNSTotal Voting Rights
3rd Jan 20197:00 amRNSAbcam to present at J.P. Morgan Conference
13th Dec 201810:06 amRNSDirectorate Change
6th Dec 20181:06 pmRNSDirector/PDMR Shareholding
3rd Dec 20184:02 pmRNSDirector/PDMR Shareholding
3rd Dec 201812:21 pmRNSTotal Voting Rights
12th Nov 20181:59 pmRNSDirector/PDMR Shareholding
8th Nov 20189:32 amRNSDirector/PDMR Shareholding
6th Nov 20185:47 pmRNSResult of AGM
2nd Nov 20188:51 amRNSTotal Voting Rights
1st Nov 20181:22 pmRNSHolding(s) in Company
29th Oct 20188:57 amRNSDirector/PDMR Shareholding
10th Oct 201810:46 amRNSHolding(s) in Company
9th Oct 20188:59 amRNSDirector/PDMR Shareholding
2nd Oct 201812:54 pmRNSHolding(s) in Company
2nd Oct 201812:51 pmRNSDirector/PDMR Shareholding
1st Oct 20185:41 pmRNSTotal Voting Rights
28th Sep 201810:11 amRNSDirector/PDMR Shareholding
24th Sep 20182:42 pmRNSHolding(s) in Company
21st Sep 201812:56 pmRNSAnnual Financial Report
14th Sep 20189:46 amRNSDirector/PDMR Shareholding
13th Sep 20181:34 pmRNSDirector/PDMR Shareholding
13th Sep 20181:33 pmRNSDirector/PDMR Shareholding
11th Sep 201810:30 amRNSDividend Payment Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.